CFDB - Cystic Fibrosis DataBase

All subcategories » congress abstract

Treatment with ivacaftor in CF patients with the G551D mutation is associated with improvement in cognition

primary studies  congress abstract

Details
  • 2018
  • Wilson J

Double-blind placebo-controlled trial of omeprazole in children with cystic fibrosis and gastroesophageal reflux disease

primary studies  congress abstract

Details
  • 2019
  • Dziekiewicz M

Safety, Efficacy, and Tolerability of Tezacaftor/Ivacaftor in Cystic Fibrosis Patients Who Previously Discontinued Lumacaftor/Ivacaftor Due To Respiratory Adverse Events: a Randomized, Double-Blind, Placebo-Controlled Phase 3b Study

primary studies  congress abstract

Details
  • 2019
  • Schwarz C

Effects of tezacaftor/ivacaftor (TEZ/IVA) treatment in patients with cystic fibrosis and F508del/F508del-CFTR: patient-reported outcomes in a Phase 3, randomised, controlled trial (EVOLVE)

primary studies  congress abstract

Details
  • 2019
  • Sommerburg O

Alternative therapies in patients with cystic fibrosis who carry minimal residual function mutations

primary studies  congress abstract

Details
  • 2019
  • Tosco A

Is telehealth as effective as face to face therapy for delivery of whole body vibration training (WBVT) as an adjunct to physiotherapy in children and young people with cystic fibrosis (CF)?

primary studies  congress abstract

Details
  • 2019
  • Alexander E

Methicillin-resistant Staphylococcus aureus eradication in cystic fibrosis patients: a randomized multicenter study

primary studies  congress abstract

Details
  • 2019
  • Dolce D

Stability of serum precipitins to Aspergillus fumigatus for the diagnosis of allergic bronchopulmonary aspergillosis

primary studies  congress abstract

Details
  • 2019
  • Lau KSK

Inhaled dry powder alginate oligosaccharide (OligoG) in cystic fibrosis: sub-group analyses of a double-blind, randomized, placebo-controlled, efficacy and safety trial

primary studies  congress abstract

Details
  • 2019
  • Rye P

A prospective mixed-methods pilot study assessing the effects of improving diabetes education in adults with cystic fibrosis (IDEA-CF)

primary studies  congress abstract

Details
  • 2019
  • Sunsoa HK